Patanjali Ayurvedic Medicines has launched ‘Coronil’ anti-COVID tablets to finght and prevent the spread of the deadly covid-19. Researched by Patanjali Research Institute with clinical trails held at NIMS University, Jaipur, the anti-corona tablet was launched by Baba Ramdev on Tuesday. Clinical control trials were carried out adhering to standardized protocols of
drug discovery to evaluate its efficacy, the company said. Within the span of 3 to 15 days, all the corona positive patients transformed into negative ones without observing any mortality, the company’s release about the tablet claims.
The COVID therapy suggested by Pantanjali is applicable for adults ranging between 15-80 years of age whereas children are advised to take half the dosage prescribed for adults. Further, Patanjali urged people to practice Yoga every morning in order
to stay protected from the covid-19 infection and to boost their immune system. Apart from boosting the pulmonary system of
the body, these Ayurvedic medicines strengthen the human physiology to encounter the Coronavirus infection, Patanjali claims.
During the launch, Patanjali co-founder Baba Ramdev said that their clinical trial found that 69% of the patients tested recovered from COVID-19 within three days, while 100% of the patients recovered within a week, as per news agency ANI.
In his post, Acharya Balkrishna had announced that it is the first and foremost evidence-based ayurvedic medicine against the coronavirus contagion. The medicine has been manufactured by Haridwar’s Divya Pharmacy and Patanjali Ayurved Limited in Haridwar, based on a joint research by Patanjali Research Institute in Haridwar and the National Institute of Medical Science, Jaipur.
In a press release, Patanjali also said that it would disclose the results of the randomised clinical trials conducted on COVID-19 patients while controlling the placebo. The trial was conducted by Patanjali Ayurvedic Medicines. The disclosure would
be made by co-founders Baba Ramdev and Acharya Balkrishna, while the scientists, doctors and researchers involved in the trial would also be present. The event would be held at the Patanjali Yogpeeth in Haridwar.
Earlier this month, ANI had quoted Acharya Balkrishna as saying that they had first conducted a simulation after which compounds that could fight the novel coronavirus were identified. He further said that they then conducted clinical trials on several patients who had tested positive for COVID-19 and the results were favourable. He had further said, according to ANI,
Patanjali to launch ayurvedic medicine for coronavirus today
— ANI Digital (@ani_digital) June 22, 2020
that after taking their medicine, the patients recovered within five to 14 days, after which they tested negative for the disease.
Coronavirus-induced COVID-19 has caused a global pandemic, due to which the number of cases all over the world have reached nearly 90 lakh. In India itself, the cases as on Monday stood at 4.25 lakh, while the total number of deaths are over 13,000. A
cure for the disease is of utmost importance at the moment, and all branches of medicine – modern as well as alternative – have been working hard towards achieving that goal.